Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Capitalistaon Aug 25, 2022 7:55am
301 Views
Post# 34919152

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:WOW!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:WOW!There may not have been any hard money offers yet.  In my experience, when Co. A expresses interest in buying Co. B and B's BoD is amenable to offers, they go through a due diligence process - B opens its books and history to A's auditors/tech experts. If all is good, A might put in an offer.  This is especially true in multi-billion dollar transactions where there is more at stake than, say, buying a used Chevy.  

The Memorandum of Understanding which usually accompanies this process might include an exclusion clause - Co. B cannot entertain other suitors until Co. A finishes its DD and decides whether or not to offer (or an agreed-upon period in lieu of this decision point). 
<< Previous
Bullboard Posts
Next >>